Before the COVID-19 pandemic hit Munich, Germany, people from all over the world gathered at the Theresienwiese for the world famous Oktoberfest. Today, the massive tent for the crowds is there for another purpose – COVID testing. And that is where BMS Germany’s Florian Gilg, medical advisor, Oncology, has been volunteering his services as a physician since late last summer.
Five–year commitment builds on long-standing investment in health equity
PRINCETON, N.J., AUGUST 12, 2020) /3BL Media/ - Bristol Myers Squibb (NYSE: BMY) and the Bristol Myers Squibb Foundation announced today a combined investment of $300 million as part of a series of commitments.
New grant from Bristol Myers Squibb will help fund projects that address gaps in access to lung cancer care in rural and Black communities
NEW YORK, July 16, 2020 /3BL Media/ – Stand Up To Cancer today announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities. Despite recent progress in treating lung cancer, the disease remains the leading cause of cancer death in the U.S. with particularly high death rates in rural communities and among Black men.
What do 633 disability leaders from 29 countries spanning six out of seven continents have in common? 100% believe that organizations led by people with disabilities are left out of disaster relief funding from foundations, corporations and governments.
LOS ANGELES, July 1, 2020 /3BL Media/ -- With nearly 11,000 patients served, including 1,000 emergency food deliveries made and over 10,000 financial assistance grants being provided in 49 states, Team Rubicon (TR) and Patient Advocate Foundation (PAF) are announcing the expansion of the COVID-19 Emergency Food Assistance Program. The program, a collaboration between TR and PAF, provides emergency food and financial assistance to people living with cancer, multiple sclerosis, and rheumatoid arthritis.
Multimillion-dollar grant to help reach Veterans in rural areas
WASHINGTON, June 3, 2020 /3BL Media/ – The U.S. Department of Veterans Affairs (VA) today announced it is teaming with the Bristol Myers Squibb Foundation (Foundation) to build new programs to enable VA oncology specialists to provide Veterans access to precision cancer care regardless of where they live.
The Foundation has committed to providing VA $4.5 million in grant funds over three years to help establish a national teleoncology center to more effectively reach Veterans living in rural communities.
PRINCETON, N.J., April 7, 2020 /3BL Media/ -Bristol Myers Squibb (NYSE: BMY) today announced an expansion of its existing patient support programs to help eligible unemployed patients in the U.S. who have lost their health insurance due to the COVID-19 pandemic.
The expanded program offers access to any branded Bristol Myers Squibb medicine for free, including some of its most widely prescribed products, as well as those prescribed via telehealth services. The program features: